Literature DB >> 11240265

Expression of granulocyte colony-stimulating factor and its receptor in epithelial skin tumors.

K Hirai1, M Kumakiri, S Fujieda, H Sunaga, L M Lao, Y Imamura, K Ueda, M Fukuda.   

Abstract

Granulocyte colony-stimulating factor receptors (G-CSFR) have been observed on the surface of not only hematopoietic cells but also several cancer cells. In the present study, we investigated the expression of G-CSFR or G-CSF in epithelial skin tumors by immunohistochemical staining. The assessments were defined by the percentage of G-CSFR or G-CSF positive cells and expressed as G-CSFR and G-CSF scores. The G-CSFR score in SCC (77.6+/-20.0%) was significantly higher than that in Bowen's disease (BD) (51.0+/-35.6%), actinic keratosis (AK) (49.3+/-34.6%) or normal skin (30.0+/-32.1%) (P=0.0004, P=0.0003, P<0.0001, respectively). The mean G-CSF score in SCC (56.7+/-27.4%) or in BD (44.1+/-31.4%) was higher than that in normal skin (24.9+/-25.8%) (P=0.0075, P<0.001, respectively). G-CSF expression in AK (29.8+/-31.2%) was lower than that in SCC (P=0.0037). There was significant positive correlation between the G-CSFR score and the G-CSF score (gamma=0.274, P=0.0107) in skin tumors. These findings suggested that the assessment of G-CSFR expression might be associated with carcinogenesis of skin tumors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11240265     DOI: 10.1016/s0923-1811(00)00131-6

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  7 in total

1.  G-CSF receptor positive neuroblastoma subpopulations are enriched in chemotherapy-resistant or relapsed tumors and are highly tumorigenic.

Authors:  Danielle M Hsu; Saurabh Agarwal; Ashley Benham; Cristian Coarfa; Denae N Trahan; Zaowen Chen; Paris N Stowers; Amy N Courtney; Anna Lakoma; Eveline Barbieri; Leonid S Metelitsa; Preethi Gunaratne; Eugene S Kim; Jason M Shohet
Journal:  Cancer Res       Date:  2013-05-16       Impact factor: 12.701

2.  G-CSF and G-CSFR are highly expressed in human gastric and colon cancers and promote carcinoma cell proliferation and migration.

Authors:  K T Morris; H Khan; A Ahmad; L L Weston; R A Nofchissey; I V Pinchuk; E J Beswick
Journal:  Br J Cancer       Date:  2014-01-21       Impact factor: 7.640

3.  Characterization of G-CSF receptor expression in medulloblastoma.

Authors:  Megan Rose Paul; Yuchen Huo; Andrea Liu; Jacqueline Lesperance; Alexandra Garancher; Robert J Wechsler-Reya; Peter E Zage
Journal:  Neurooncol Adv       Date:  2020-05-27

4.  Dedifferentiated liposarcoma with leukocytosis. A case report of G-CSF-producing soft-tissue tumors, possible association with undifferentiated liposarcoma lineage.

Authors:  Akio Sakamoto; Hiroshi Matono; Tatsuya Yoshida; Kazuhiro Tanaka; Shuichi Matsuda; Yoshinao Oda; Yukihide Iwamoto
Journal:  World J Surg Oncol       Date:  2007-11-16       Impact factor: 2.754

5.  Initial Hyperleukocytosis and Neutrophilia in Nasopharyngeal Carcinoma: Incidence and Prognostic Impact.

Authors:  Zhen Su; Yan-Ping Mao; Pu-Yun OuYang; Jie Tang; Fang-Yun Xie
Journal:  PLoS One       Date:  2015-09-03       Impact factor: 3.240

6.  Granulocyte colony-stimulating factor receptor signalling via Janus kinase 2/signal transducer and activator of transcription 3 in ovarian cancer.

Authors:  J Kumar; F W Fraser; C Riley; N Ahmed; D R McCulloch; A C Ward
Journal:  Br J Cancer       Date:  2013-11-12       Impact factor: 7.640

7.  Genomic analysis of the prognostic value of colony-stimulating factors (CSFs) and colony-stimulating factor receptors (CSFRs) across 24 solid cancer types.

Authors:  Xinyi Huang; Pingping Hu; Jiandong Zhang
Journal:  Ann Transl Med       Date:  2020-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.